Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
about
MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivationThe role of glucocorticoids for spiral ganglion neuron survival.Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids.RNA-Seq transcriptome profiling identifies CRISPLD2 as a glucocorticoid responsive gene that modulates cytokine function in airway smooth muscle cells.Serum cholesterol selectively regulates glucocorticoid sensitivity through activation of JNKDifferential response of chondrocytes and chondrogenic-induced mesenchymal stem cells to C1-OH tributanoylated N-acetylhexosamines.Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionate.Feed-forward transcriptional programming by nuclear receptors: regulatory principles and therapeutic implicationsStructural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors.Real-time analysis of gene regulation by glucocorticoid hormonesThe role of the circadian clock in rheumatoid arthritis.A ligand-specific kinetic switch regulates glucocorticoid receptor trafficking and function.Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening.Dental pulp response to collagen and pulpotec cement as pulpotomy agents in primary dentition: A histological study.Recent advances in the development of novel glucocorticoid receptor modulators.Rational structure-based drug design and optimization in the ligand-binding domain of the glucocorticoid receptor-α.Rational ligand-based virtual screening and structure-activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-α.Non-genomic effect of glucocorticoids on cardiovascular system.Fast beneficial systemic anti-inflammatory effects of inhaled budesonide and formoterol on circulating lymphocytes in asthma.
P2860
Q28289862-AB5452B9-36B1-40F1-BC65-3E6A1EE11074Q30480943-AA3C8A42-3D2C-4FC9-AC8E-27DC47F97473Q33719222-839FFF17-B6A2-4AD2-BA9C-40EE2EFF7D4BQ33753415-A97CE83C-E544-4F37-9D49-CFFAD8E374ACQ34312197-5BC7ECE5-68FC-4C4F-838D-AC9AA91FAB31Q34630144-F6016FA6-D8AE-449D-BC5F-94FF00FC89CEQ34738020-C6A354DB-8E9C-45F2-9497-EFA8B5B12592Q35067776-FF7E40BA-D0A8-4AAC-8EAA-969344C32FF4Q35562822-4CEB7F95-9333-4250-8911-A71A8C69135DQ36562967-B3C00F97-2A22-49B9-B01A-F0994063E882Q36903114-38EFAA19-5846-4E24-9B4F-857AA2143135Q37012031-BB884061-20E1-4161-95CA-F3590A660C78Q37140046-61025B24-E90F-4FCB-B9F4-33029A34012BQ37186671-B3E1ACE9-ADBE-4DBC-A951-70DC59991E31Q37765564-D21302C6-7ABC-415A-AB96-A563FAFFD84BQ37855809-B3809164-608F-4BF8-9A34-1F0EB4F9374CQ37855890-56BF4950-7CD2-4B46-8DE3-7E8CEC19BA2FQ38045751-A79A7227-BFFE-4E9B-AA5D-E2846056E41CQ46951348-A7D81DF2-3656-4C7D-B3EC-9BAB7EE31A5A
P2860
Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Modelling the glucocorticoid r ...... ects but reduced side-effects.
@ast
Modelling the glucocorticoid r ...... ects but reduced side-effects.
@en
type
label
Modelling the glucocorticoid r ...... ects but reduced side-effects.
@ast
Modelling the glucocorticoid r ...... ects but reduced side-effects.
@en
prefLabel
Modelling the glucocorticoid r ...... ects but reduced side-effects.
@ast
Modelling the glucocorticoid r ...... ects but reduced side-effects.
@en
P2860
P1476
Modelling the glucocorticoid r ...... ects but reduced side-effects.
@en
P2093
Andrew McMaster
P2860
P304
P356
10.1113/EXPPHYSIOL.2006.036194
P50
P577
2006-11-30T00:00:00Z